SS Innovations Submits FDA Response for SSi Mantra Surgical Robot, Moving Closer to U.S. Market Entry

SS Innovations has submitted its response to the FDA's request for additional information on its 510(k) submission for the SSi Mantra surgical robotic system, potentially paving the way for U.S. market introduction in early 2027.

Chicago Metrowire Staff
••Healthcare
SS Innovations Submits FDA Response for SSi Mantra Surgical Robot, Moving Closer to U.S. Market Entry

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has taken a significant step toward bringing its SSi Mantra surgical robotic system to the United States. The company announced on Oct. 5, 2026, that it submitted its response to the U.S. Food and Drug Administration's request for additional information regarding its 510(k) submission for the SSi Mantra. The response includes final data from an expanded human clinical and human factors validation study, along with a bridging study completed in August 2026 at Hospital Internacional de Colombia, a member of the Mayo Clinic Care Network.

The submission covers the initial indication of cholecystectomy, or gallbladder removal. SS Innovations anticipates that the FDA will complete its review of the response and the 510(k) submission in the first quarter of 2027. This timing is critical for the company as it seeks to introduce the SSi Mantra system to the U.S. market, where demand for cost-effective robotic surgery solutions continues to grow. For investors and industry observers, the FDA's acceptance and eventual clearance would represent a major milestone, validating the system's safety and efficacy and opening access to one of the world's largest healthcare markets.

The SSi Mantra is a modular, multi-arm surgical robotic system with advanced features including 3 to 5 robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and a touch panel monitor for patient-related information. It also offers optional telesurgery capability through the SSi MantrAsana tele-surgeon console, which provides enhanced portability and ergonomic flexibility. The system utilizes over 40 different types of robotic endo-surgical instruments, supporting specialties such as cardiac surgery, and includes 5mm instruments for pediatric and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon, aiming to improve safety and efficiency.

The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures, demonstrating its versatility and reliability. This extensive clinical experience, combined with the recent human factors and bridging study data, strengthens the company's position as it seeks U.S. regulatory clearance. SS Innovations, headquartered in India but a U.S. company, focuses on making robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra system and the comprehensive suite of SSi Mudra surgical instruments.

For more information, visit the company's website at ssinnovations.com or its LinkedIn page. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. To view the full press release, visit https://ibn.fm/A6dJ8.

This announcement matters because it signals progress in the regulatory process for a robotic surgical system that could disrupt the U.S. market by offering a more affordable alternative to existing platforms. If cleared, the SSi Mantra would provide hospitals and surgeons with a cost-effective option, potentially expanding access to robotic surgery for a broader patient population. The FDA's decision, expected in early 2027, will be closely watched by investors, healthcare providers, and competitors alike. For SS Innovations, success in the U.S. would mark a transformative expansion of its global footprint and reinforce its mission to democratize advanced surgical care. As the company awaits the FDA's review, its submission underscores the growing momentum behind its technology and the increasing demand for innovative, accessible medical solutions.

Blockchain Registration

QR Code for Blockchain Registration